コンテンツにスキップ

CD34

出典: フリー百科事典『ウィキペディア(Wikipedia)』
CD34
識別子
記号CD34, entrez:947, CD34 molecule
外部IDOMIM: 142230 MGI: 88329 HomoloGene: 1343 GeneCards: CD34
遺伝子の位置 (ヒト)
1番染色体 (ヒト)
染色体1番染色体 (ヒト)[1]
1番染色体 (ヒト)

CD34遺伝子の位置

CD34遺伝子の位置

バンドデータ無し開始点207,880,972 bp[1]
終点207,911,402 bp[1]
遺伝子の位置 (マウス)
1番染色体 (マウス)
染色体1番染色体 (マウス)[2]
1番染色体 (マウス)

CD34遺伝子の位置

CD34遺伝子の位置

バンドデータ無し開始点194,621,127 bp[2]
終点194,643,587 bp[2]
RNA発現パターン
さらなる参照発現データ
遺伝子オントロジー
分子機能 転写因子結合
sulfate binding
炭水化物結合
細胞の構成要素 細胞質
integral component of membrane

細胞膜
integral component of plasma membrane
細胞外領域
cell surface
basal plasma membrane
glomerular endothelium fenestra
apical plasma membrane
intercellular bridge
perinuclear region of cytoplasm
リソソーム
external side of plasma membrane
細胞周辺
生物学的プロセス extracellular exosome assembly
stem cell proliferation
positive regulation of interleukin-10 production
cell motility
negative regulation of blood coagulation
metanephric glomerular mesangial cell differentiation
傍分泌シグナル伝達
hematopoietic stem cell proliferation
positive regulation of granulocyte colony-stimulating factor production
遺伝子発現の負の調節
positive regulation of angiogenesis
regulation of blood pressure
vascular wound healing
positive regulation of gene expression
glomerular filtration
negative regulation of nitric oxide biosynthetic process
細胞接着
endothelial cell proliferation
mesangial cell-matrix adhesion
tissue homeostasis
positive regulation of vasculogenesis
endothelium development
regulation of immune response
negative regulation of cellular response to heat
positive regulation of transforming growth factor beta production
glomerular endothelium development
negative regulation of tumor necrosis factor production
cell-matrix adhesion
細胞増殖
positive regulation of odontogenesis
negative regulation of cellular response to hypoxia
leukocyte migration
シグナル伝達
分化転換
negative regulation of neuron death
cell-cell adhesion
造血
出典:Amigo / QuickGO
オルソログ
ヒトマウス
Entrez
Ensembl
UniProt
RefSeq
(mRNA)

NM_001025109
NM_001773

NM_001111059
NM_133654

RefSeq
(タンパク質)

NP_001020280
NP_001764

NP_001104529
NP_598415

場所
(UCSC)
Chr 1: 207.88 – 207.91 MbChr 1: 194.62 – 194.64 Mb
PubMed検索[3][4]
ウィキデータ
閲覧/編集 ヒト閲覧/編集 マウス

CD34cluster of differentiation 34CD34[5][6][7]

CD34CDCD34CivinTindle[8][9][10][11]CD34CD34CD34CD34[12]

[]


CD341[13][14]

CD34TCD34TL-[15][16]CD34[17][18]CD34[19][20]CD34[13][19]

[]


CD34[12]

LT-HSCLinCD34CD38CD34+CD38[21][22][23]LinCD34+CD38LT-HSC[24][25][26]

CD3420%[27][28]

[]


CD34CD34CD34[29]CD34宿CD34[30]

CD34[31]

[]


CD34CRKL[32]

出典[編集]

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000174059 - Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000016494 - Ensembl, May 2017
  3. ^ Human PubMed Reference:
  4. ^ Mouse PubMed Reference:
  5. ^ Entrez Gene: CD34 CD34 molecule”. 2023年3月11日閲覧。
  6. ^ “Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells”. Journal of Immunology 148 (1): 267–271. (January 1992). PMID 1370171. http://www.jimmunol.org/cgi/content/abstract/148/1/267. 
  7. ^ “Structure of the gene encoding CD34, a human hematopoietic stem cell antigen”. Genomics 12 (4): 788–794. (April 1992). doi:10.1016/0888-7543(92)90310-O. PMID 1374051. 
  8. ^ “Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells”. Journal of Immunology 133 (1): 157–165. (July 1984). PMID 6586833. 
  9. ^ “A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow”. Leukemia Research 9 (1): 1–9. (1985). doi:10.1016/0145-2126(85)90016-5. PMID 3857402. 
  10. ^ Tindle RW. Katz F. Martin H. Watt D. Catovsky D. Janossy G. Greaves M. (1987). “BI-3C5 (CD34) defines multipotential and lineage restricted progenitor cells and their leukaemic counterparts .”. In 'Leucocyte Typing 111: White Cell Differentiation Antigens. Oxford University Press, 654-655. 
  11. ^ Loken M. Shah V. Civin CI.. (1987). “Characterization of myeloid antigens on human bone marrow using multicolour immunofluorescence”. In: McMichael, Leucocyte Typing III:White Cell Differentiation Antigens.Oxford University Press 630-635. 
  12. ^ a b “Concise review: evidence for CD34 as a common marker for diverse progenitors”. Stem Cells 32 (6): 1380–1389. (June 2014). doi:10.1002/stem.1661. PMC 4260088. PMID 24497003. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260088/. 
  13. ^ a b “Novel functions of the CD34 family”. Journal of Cell Science 121 (Pt 22): 3683–3692. (November 2008). doi:10.1242/jcs.037507. PMID 18987355. 
  14. ^ “Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis”. Immunologic Research 34 (1): 13–32. (2006). doi:10.1385/IR:34:1:13. PMID 16720896. 
  15. ^ “Complexity and differential expression of carbohydrate epitopes associated with L-selectin recognition of high endothelial venules”. The American Journal of Pathology 152 (2): 469–477. (February 1998). PMC 1857953. PMID 9466573. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857953/. 
  16. ^ “Preferential induction of peripheral lymph node addressin on high endothelial venule-like vessels in the active phase of ulcerative colitis”. The American Journal of Gastroenterology 102 (7): 1499–1509. (July 2007). doi:10.1111/j.1572-0241.2007.01189.x. PMID 17459027. 
  17. ^ “CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution”. Immunity 22 (1): 43–57. (January 2005). doi:10.1016/j.immuni.2004.11.014. PMID 15664158. 
  18. ^ “The molecular basis of vascular lumen formation in the developing mouse aorta”. Developmental Cell 17 (4): 505–515. (October 2009). doi:10.1016/j.devcel.2009.08.011. PMID 19853564. 
  19. ^ a b “CD34 facilitates the development of allergic asthma”. Blood 110 (6): 2005–2012. (September 2007). doi:10.1182/blood-2006-12-062448. PMID 17557898. 
  20. ^ “CD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitis”. American Journal of Respiratory and Critical Care Medicine 184 (6): 687–698. (September 2011). doi:10.1164/rccm.201011-1764OC. PMC 3208601. PMID 21642249. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208601/. 
  21. ^ “Distinct requirements for optimal growth and In vitro expansion of human CD34(+)CD38(-) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells”. Blood 94 (12): 4093–4102. (December 1999). doi:10.1182/blood.V94.12.4093. PMID 10590054. 
  22. ^ “Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice”. Proceedings of the National Academy of Sciences of the United States of America 99 (1): 413–418. (January 2002). Bibcode2002PNAS...99..413H. doi:10.1073/pnas.012336799. PMC 117574. PMID 11782553. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC117574/. 
  23. ^ “Reconstitution of human haematopoiesis in non-obese diabetic/severe combined immunodeficient mice by clonal cells expanded from single CD34+CD38- cells expressing Flk2/Flt3”. British Journal of Haematology 119 (2): 525–534. (November 2002). doi:10.1046/j.1365-2141.2002.03820.x. PMID 12406096. 
  24. ^ “Low rhodamine 123 retention identifies long-term human hematopoietic stem cells within the Lin-CD34+CD38- population”. Blood 109 (2): 543–545. (January 2007). doi:10.1182/blood-2006-06-030270. PMID 16990597. 
  25. ^ “In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection”. Experimental Hematology 21 (5): 614–622. (May 1993). PMID 8513861. 
  26. ^ “The endoglin(positive) sca-1(positive) rhodamine(low) phenotype defines a near-homogeneous population of long-term repopulating hematopoietic stem cells”. Immunity 19 (4): 525–533. (October 2003). doi:10.1016/s1074-7613(03)00265-6. PMID 14563317. 
  27. ^ “CD34 expression by murine hematopoietic stem cells. Developmental changes and kinetic alterations”. Annals of the New York Academy of Sciences 938 (1): 139–145. (June 2001). Bibcode2001NYASA.938..139O. doi:10.1111/j.1749-6632.2001.tb03583.x. PMID 11458501. 
  28. ^ “CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor”. Blood 96 (5): 1989–1993. (September 2000). doi:10.1182/blood.V96.5.1989. PMID 10961905. 
  29. ^ “Single-cell analysis of bone marrow-derived CD34+ cells from children with sickle cell disease and thalassemia”. Blood 134 (23): 2111–2115. (December 2019). doi:10.1182/blood.2019002301. PMC 7259822. PMID 31697810. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259822/. 
  30. ^ “Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation”. Biology of Blood and Marrow Transplantation 24 (5): 1079–1087. (May 2018). doi:10.1016/j.bbmt.2018.01.001. PMC 6529210. PMID 29325829. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529210/. 
  31. ^ “Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience”. Cytotherapy 13 (8): 993–999. (September 2011). doi:10.3109/14653249.2011.579961. PMID 21671823. 
  32. ^ “The adapter protein CrkL associates with CD34”. Blood 97 (12): 3768–3775. (June 2001). doi:10.1182/blood.V97.12.3768. PMID 11389015. 

関連文献[編集]

関連項目[編集]

外部リンク[編集]